Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Issues / 2022 / Aug / Of Mice and MA10
Microbiology & Immunology Microbiology and Immunology Infectious Disease

Of Mice and MA10

Mice infected with the SARS-CoV-2 MA10 strain provide insight into mechanisms behind long COVID-19 in humans

By Liv Gaskill 08/22/2022 News 2 min read

Share

Since the start of the COVID-19 pandemic, scientists have known that SARS-CoV-2 infection can lead to long-term consequences throughout the body, but research into the mechanisms behind lung abnormalities associated with post-acute sequelae of SARS-CoV-2 (PASC) lack longitudinal tissue samples. Mice infected with the mouse-adapted MA10 strain suffer from acute respiratory distress syndrome similar to humans – providing researchers with a prime reference for studying PASC pathogenesis.

Recognizing this, researchers from the University of North Carolina at Chapel Hill extended studies of MA10-infected mice from acute to clinical recovery phases to investigate PASC pathogenesis (1). The mice were autopsied at two, seven, 15, 30, 60, and 120 days post-infection, matching recommendations for diagnosing COVID-19 phases in humans.

Credit: Image sourced from Unsplash.com

By extending the studies to 120 days in one-year-old BALB/c mice, the team demonstrated that many chronic phenotypes seen at 15 days post-infection were also observed for the whole 120-day period – ranging from acute to ongoing to chronic COVID-19 classifications that are also used in humans. Furthermore, fibrotic pulmonary disease peaked at 15 days post-infection in young BALB/c and aged C57BL/6J mice, but waned by 30 days post-infection in many animals compared with aged BALB/c mice. This finding suggests that multiple time points for extended time intervals are needed in future studies of other viral pathogens.

Surviving mice also exhibited higher levels of pro-inflammatory and pro-fibrotic cytokines and, though most returned to normal by the 30-day observation, there was prolonged up-regulation of TGF-β signaling in subpleural fibrotic regions. Early intervention with anti-fibrotic agent nintedanib and antiviral EIDD-2801 modified disease severity and reduced chronic disease, respectively.

The SARS-CoV-2 MA10 mouse model could provide the opportunity for scientists to investigate longitudinal molecular mechanisms behind post-COVID-19 pulmonary disease and monitor the effects of early intervention to improve the long-term consequences of PASC.

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. KH Dinnon et al., Sci Transl Med, [Online ahead of print] (2022). PMID: 35857635.

About the Author(s)

Liv Gaskill

During my undergraduate degree in psychology and Master’s in neuroimaging for clinical and cognitive neuroscience, I realized the tasks my classmates found tedious – writing essays, editing, proofreading – were the ones that gave me the greatest satisfaction. I quickly gathered that rambling on about science in the bar wasn’t exactly riveting for my non-scientist friends, so my thoughts turned to a career in science writing. At Texere, I get to craft science into stories, interact with international experts, and engage with readers who love science just as much as I do.

More Articles by Liv Gaskill

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Context Matters in Cancer Biology
Microbiology and Immunology
Context Matters in Cancer Biology

December 27, 2021

1 min read

Akoya is leading the way with spatial phenotypic signatures – a novel class of biomarkers for predicting response to immunotherapy

What’s New in Infectious Disease? (December 2021)
Microbiology and Immunology
What’s New in Infectious Disease?

December 23, 2021

1 min read

The latest research and news on COVID-19 and the infectious disease landscape

Immunology Insights
Microbiology and Immunology
Immunology Insights

January 13, 2022

1 min read

The latest research in pathology and laboratory medicine

2021: A Laboratory Medicine Roundup
Microbiology and Immunology
2021: A Laboratory Medicine Roundup

January 18, 2022

3 min read

From transgender health care to the power of pathology podcasts, we take a look at our most popular articles of the last year

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.